Certara
Certara Inc is an American biosimulation and drug development technology enterprise headquartered in Princeton, New Jersey. The company provides specialized software, regulatory science consulting, and biosimulation services to pharmaceutical, biotechnology, and academic research organizations globally. Its proprietary technology platforms simulate the pharmacokinetics and pharmacodynamics of drug candidates to optimize clinical trial design and accelerate drug development. Principal revenue is generated through software license subscriptions, consulting service fees, and analytical support contracts. Certara Inc is publicly listed on the Nasdaq Stock Market.
2 of the funds FundTelligence covers report a position in Certara.
- Legal name
- CERTARA
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 2
Funds holding Certara
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.13 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)